Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
By vaccinating SARS-CoV-2 naïve individuals who have already received two doses of COVID-19 vaccines, we aimed to investigate whether a heterologous prime-boost strategy, using vaccines of different platforms as the booster dose, can enhance the immune response against SARS-CoV-2 virus variants. Par...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2022-01-01
|
| Serija: | Vaccines |
| Teme: | |
| Online dostop: | https://www.mdpi.com/2076-393X/10/2/160 |
| Oznake: |
Brez oznak, prvi označite!
|
